Abstract: The present invention provides a use of a growth factors-enriched dry powder for relieving inflammation or injury, wherein each gram of the growth factors-enriched dry powder comprises more than or equal to 9×104 pg of PDGF-BB.
Abstract: The present invention provides a use of platelet dry powder (PDP) for relieving inflammation or injury in an airway portion, wherein per gram of platelet dry powder (PDP) comprises at least 100,000 platelets.
Type:
Application
Filed:
June 16, 2022
Publication date:
December 22, 2022
Applicants:
Spirit Scientific Co. LTD.
Inventors:
Chin-Ho Chen, Yi-Shin Tsai, Tzu-Min Yang, Dao Lung Steven Lin